Centralised authorisation procedure 2013
The Danish share of assignments in the European pharmaceutical collaboration
The Danish Medicines Agency should have the greatest possible influence on decisions regarding new medicinal products and thereby the greatest possible influence on the future development of the European market for medicinal products.
Status for 2013 up to and including 4th quarter
Denmark was assigned 4 human rapporteur/co-rapporteur cases and 5 veterinary rapporteur/co-rapporteur case, which is respectively 2 % and 7 % of all assigned central procedure cases in 2013.
Figure 1: Amount of assigned (co)rapporteurships in the EU in 2013 up to and including 4th quarter
Figure 2. Share of human Rap/Co-rap cases in 2013 up to and including 4th quarter
Figure 3. Share of veterinary Rap/Co-rap cases in 2013 up to and including 4th quarter